A study on the impact of SARS-CoV-2 on the HPA axis found that some COVID-19 patients had lower levels of dehydroepiandrosterone sulfate (DHEAS) and adrenocorticotropic hormone (ACTH) in the morning (51–53). Here, POMC is linked to COVID-19.